Viewing Study NCT05322850


Ignite Creation Date: 2025-12-24 @ 4:46 PM
Ignite Modification Date: 2026-02-17 @ 11:06 PM
Study NCT ID: NCT05322850
Status: RECRUITING
Last Update Posted: 2025-12-15
First Post: 2022-03-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT)
Sponsor: University of Florida
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Myeloid Leukemia View
None Acute Lymphoid Leukemia View
None Mixed Phenotype Acute Leukemia View
None Acute Undifferentiated Leukemia View
None Chronic Myeloid Leukemia in Myeloid Blast Crisis View
None Chronic Myeloid Leukemia in Lymphoid Blast Crisis (Diagnosis) View
None Chronic Myeloid Leukemia - Accelerated Phase View
Keywords:

Keywords

Keyword Brief Keyword Text View
None hematologic malignancies View
None Orca-Q View
None hematopoietic cell transplant View
None engineered donor graft View
None pediatrics View